SYK Stock Chart & Fundamental Analysis

Interactive Chart

About Stryker Corporation

Name

Stryker Corporation

CEO

Kevin A. Lobo

Website

www.stryker.com

Industry

Healthcare

Year Founded

1941

Employees

53,000

Stryker Corporation is a medical technology company that develops implants, surgical equipment, and patient care solutions used in hospitals and ambulatory centers. Its focus is practical: help clinicians restore mobility, perform procedures with confidence, and manage recovery under clear protocols. Engineering teams work with surgeons and care staff to refine instruments and workflows so products fit existing routines. Manufacturing and quality systems aim for dependable availability once a therapy is adopted. Education, service, and digital tools support safe use over long lifecycles. The company operates across many regions and clinical settings, but the promise remains the same: devices and systems that integrate cleanly into real care, backed by training and support that keep operating rooms and wards prepared for the next case.

Analyst Ratings

Consensus Recommendation

Buy9

Hold8

Sell4

Fundamentals & Financials

Revenue (TTM)

$24.3B

Net Income (TTM)

$2.9B

EPS (TTM)

$7.71

ROA (TTM)

6.25%

Current Ratio

1.85

Dividend Yield

0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)

Item	Q3 2025	Q2 2025	Q1 2025
Revenue	$6,057M	$6,022M	$5,866M
Cost of Sales	$2,205M	$2,272M	$2,186M
Gross Profit	$3,852M	$3,750M	$3,680M
Operating Income	$1,135M	$1,361M	$1,179M
Net Income	$859,000K	$884,000K	$654,000K
EPS	$2.25	$2.32	$1.71

Balance Sheet (Quarterly)

Financial Highlights (Quarterly)

Dividends History

Split History

Earnings Calendar (Quarterly)

Technical Indicators

Stryker Corporation's Technical Indicators Summary

SYK is currently trading near 364, positioned above its short- and medium-term moving averages, which generally suggests some upward momentum, supported by a positive MACD and momentum readings. However, the longer-term averages remain above the current price, indicating resistance at higher levels. The trend strength is relatively weak, as the ADX is low, reflecting a lack of a strong directional movement. Volatility is moderate, with the ATR showing steady price fluctuations, while volume indicators like OBV hint at some buying interest. Overall, these mixed signals contribute to a neutral technical outlook, with the stock neither showing clear strength nor weakness at this time.

Buy

9 signals

Neutral

8 signals

Sell

4 signals

Overall: Neutral38% Neutral signals

Indicator	Value	Signal	Explanation
RSI (14)	55.15	Neutral	RSI (55.15) is neutral.
Stochastic %K (14, 3, 3)	65.74	Neutral	Stochastic (65.74) is neutral.
CCI (20)	80.28	Neutral	CCI (80.28) is neutral.
WPR (14)	-27.05	Neutral	Williams %R (-27.05) is neutral.
Momentum (10)	15.60	Buy	Momentum (15.60) is positive.
MFI	51.98	Neutral	MFI (51.98) is neutral.
MACD Level (12, 26)	0.91	Buy	Confirmed uptrend: MACD (0.91) is positive and above its signal line (-0.02).
Bollinger Bands	$345.20 - $370.34	Neutral	Price is within the bands.
ATR (14)	$6.83 (1.88%)	Neutral	Moderate Volatility (1.88%).
ADX (14)	14.54	Neutral	Weak or consolidating trend (ADX < 25). ADX(14.54), +DI(22.12), -DI(22.89)
OBV	-17,092,000	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(-17,092,000), 20D-SMA-OBV(-21,489,855)
Exponential Moving Averages	$359.61 - $372.05(5 indicators)	Buy	The price is trading above the short- to mid-term EMAs (10, 20, 50), indicating near-term bullish momentum, but remains below the longer-term EMAs (100, 200), suggesting the broader trend is still bearish.
Simple Moving Averages	$357.77 - $374.17(5 indicators)	Buy	The price is trading above the short- to mid-term SMAs (10, 20, and 50 periods), indicating near-term bullish momentum, but remains below the longer-term SMAs (100 and 200 periods), suggesting the overall trend is still bearish.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the bell, SYK remained somewhat elevated, with the 0.851% gap versus yesterday leaving it around 362.67. End-of-day derivatives positioning for SYK stayed heavily call-biased, with PCR at a very low 0.39. SYK remains elevated amid call-biased derivatives, with recent news highlighting industry growth and M&A activity.

Price Change

from $359.61 close

+$3.06

Trading Volume

Below avg (2.0M)

1.5M

vs S&P 500 Today

Outperforming Market

+1.87%

52-Week Position

Mid-range

43.5%